A subset of AML patients with adverse prognosis shows high expression of certain hematopoietic stem and progenitor cell-associated transcription factors [33-35], especially the heptade SCL, LYL1, LMO2, GATA2, RUNX1, FLI1 and ERG [34]. The gene discussed is LMO2; the disease is acute myeloid leukemia.